각막측정기 시장 : 점유율 분석, 산업 동향 및 통계, 성장 예측(2024-2029년)

The Keratometers Market size is estimated at USD 308.84 million in 2024, and is expected to reach USD 404.42 million by 2029, growing at a CAGR of 5.54% during the forecast period (2024-2029).

The COVID-19 pandemic disrupted the treatment and diagnostic activities of diseases other than COVID-19. It impacted the treatment procedures and supply chain of pharmaceuticals and medical devices worldwide, adversely impacting the studied market. For instance, according to the Carl Zeiss annual report 2022, the revenue in the ophthalmic devices strategic business unit (SBU), including keratometers, decreased by -7.3% during the pandemic. However, the revenue from the ophthalmic devices strategic business unit increased by 17% in FY2022. It shows the declined sales revenue of ophthalmic devices like keratometers during the pandemic, which recovered due to a resumed supply chain and diagnostic activities in the healthcare facilities.

The factors driving the market include the increasing burden of eye disorders and growing investments, funds, and grants. The high burden of eye disorders increases the demand for keratometers, which is expected to grow significantly. For instance, as per the report published by InSight Vision Center in December 2021, 23% of infants aged 6 to 12 months would include common astigmatism. Similarly, according to the October 2022 report of the WHO, about 2.2 billion people around the world suffer from near or distant vision impairment, of which approximately 1 billion cases of vision impairment can be prevented. It shows the high burden of the cases of vision impairment. It is expected to include a high demand for the diagnosis using keratometers and likely boost the market over the study period.

Furthermore, the new strategies and initiatives by the market players are expected to significantly impact the market. For instance, in May 2021, ZEISS expanded its national coverage in the United States for its Industrial Quality & Research segment by acquiring Capture 3D. With this acquisition, customers benefitted from a seamless, integrated experience to get the best measuring solutions, and it is expected to propel the market over the stud period.

However, the need for primary infrastructure for eye-related diseases in underdeveloped and developing countries hampers overall market growth.

Keratometers Market Trends

Hospitals are Expected to Hold a Significant Market Share Over the Forecast Period

The increasing number of hospitals is the primary factor for market growth. The number of hospitals is growing at a steady pace in various countries like the United States and Mexico. For instance, according to the American Hospital Association 2022 report, there are 6,093 hospitals in the United States. However, the Definitive Healthcare HospitalView product tracks 7,308 active United States hospitals as of March 2022. These hospital facilities are curated from 40 public, private, and proprietary sources. Increasing investment is another factor for market growth.

The report published by India Brand Equity Foundation in December 2021 stated that Foreign Direct Investment (FDI) inflows for the drugs and pharmaceuticals sector stood at USD 19.19 billion, according to the data released by the Department for Promotion of Industry and Internal Trade (DPIIT). FDI inflows in sectors such as hospitals, diagnostic centers, and medical and surgical appliances stood at USD 7.73 billion and USD 2.35 billion, respectively.

The same source stated that the Indian government plans to introduce a credit incentive program worth INR 500 billion (USD 6.8 billion) to boost the country's healthcare infrastructure. The program will allow firms to leverage the fund to expand hospital capacity or medical supplies, with the government acting as a guarantor. Such initiatives and investments would increase the end-user facilities by adopting various medical devices, including keratometers. Hence, the factors mentioned above are expected to drive the growth of the studied segment during the forecast period.

North America is Expected to Hold the Significant Share in the Market Over the Forecast Period

The North American region is expected to hold a significant market share over the forecast period. Factors such as investments, increasing eye disorders, and research studies will likely increase market growth. According to the NCHS at CDC in March 2023, the research funding for eye disease and disorders of vision was USD 1,070 million in 2021, which was increased to USD 1,097 million in 2022 and is estimated to be USD 1,163 million in 2023. It shows the increasing research funding on eye disease and vision disorders, which is expected to significantly impact keratometer usage, propelling the market's growth over the forecast period.

Keratometry measures the cornea's curvature to calculate corneal astigmatism along with posterior corneal astigmatism and posterior and anterior crystalline lens astigmatism, which is minimal in many cases. Astigmatism is the most frequent ammetropia. Increasing prevalence will increase the demand for keratometers, which is expected to boost the market's growth in the region. For instance, as per the report published by NVISION Eye Centers in December 2022, astigmatism occurs in about one out of every three people in the United States. In addition, farsightedness occurs in about 8.4% of the population over 40, and nearsightedness occurs in about 23.9% of the population over 40 years old. It shows the high burden of vision impairment, which increases keratometers' usage and propels market growth.

Keratometers Industry Overview

The market is moderately consolidated and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, that help them strengthen their market positions. Further, the increase in research and development activities initiated by the key players also favors market growth. Some companies currently dominating the market are Carl Zeiss AG, Essilor, Visionix (Luneau Technology), Reichert, Inc., and NIDEK CO., LTD.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Eye Disorders
  • 4.2.2 Growing Investments, Funds, and Grants on Eye Care Devices
• 4.3 Market Restraints
  • 4.3.1 Lack of Primary Infrastructure For Eye Related Diseases in Underdeveloped and Developing Countries
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Bargaining Power of Suppliers
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Threat of New Entrants
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

• 5.1 By Type
  • 5.1.1 Stationary Type Keratometers
  • 5.1.2 Portable Type Keratometers
• 5.2 By End User
  • 5.2.1 Hospitals
  • 5.2.2 Eye Clinics
  • 5.2.3 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Carl Zeiss AG
  • 6.1.2 Costruzione Strumenti Oftalmici
  • 6.1.3 Essilor
  • 6.1.4 Visionix (Luneau Technology)
  • 6.1.5 Topcon Corporation
  • 6.1.6 Micro Medical Devices
  • 6.1.7 Naugra Medical
  • 6.1.8 NIDEK CO., LTD
  • 6.1.9 TOMEY GmbH
  • 6.1.10 Reichert, Inc
  • 6.1.11 SHIGIYA MACHINERY WORKS LTD GS Division
  • 6.1.12 Canon Medical Systems Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS